| 
 | |||||
|   | 
| 
 | 

Reinsurance provider RenaissanceRe (NYSE:RNR) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 19.5% year on year to $3.20 billion. Its non-GAAP profit of $15.62 per share was 64.4% above analysts’ consensus estimates.
Is now the time to buy RNR? Find out in our full research report (it’s free for active Edge members).
RenaissanceRe’s third quarter was characterized by a sharp decline in sales but a substantial outperformance on both revenue and non-GAAP earnings relative to Wall Street expectations, which prompted a significant positive market reaction. Management attributed the results to disciplined underwriting, a continued focus on property catastrophe (CAT) risk selection, and robust growth in fee and investment income. CEO Kevin O’Donnell emphasized that the company’s ability to “preserve underwriting margin” and generate stable, recurring returns from capital partner fees and investment activities helped mitigate the impact of lower top-line growth. O’Donnell highlighted that “our strong earnings engine... will continue to generate enduring value for our shareholders in the fourth quarter and beyond.”
Looking ahead, RenaissanceRe’s management is prioritizing margin preservation over top-line growth in a competitive reinsurance market, with expectations that property CAT rates may decline but remain attractive relative to risk. The company is also closely monitoring shifts in demand and supply, particularly as third-party capital becomes more engaged in longer-tail lines of business. CFO Bob Qutub reaffirmed, “We anticipate continuing share buybacks, consistent with our long-term track record of being good stewards of our shareholders’ capital.” Management believes that a disciplined approach to risk selection, capital deployment, and expanding fee-based income will support continued growth in tangible book value per share even as market conditions evolve.
Management pointed to robust fee and investment income, alongside a disciplined underwriting approach, as central to the quarter’s strong performance, even as revenue declined year over year.
RenaissanceRe expects disciplined risk selection, evolving capital management, and shifts in reinsurance market supply and demand to shape its outlook for the coming quarters.
In upcoming quarters, the StockStory team will be monitoring (1) the January 1 renewal season for signs of rate discipline and successful portfolio optimization, (2) continued growth and stability in capital partner fees and investment income, and (3) the pace and consistency of share repurchases as a means of capital management. We will also watch for any shifts in competitive dynamics, especially as third-party capital plays a larger role in longer-tail segments.
RenaissanceRe currently trades at $247, up from $231.59 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free for active Edge members).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| 6 hours | |
| 11 hours | |
| 11 hours | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-29 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-26 | 
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite